Glioma cells release neurotoxic glutamate, partly via cystine/glutamate exchangers, to stimulate proliferation; reduced EAAT1/2 (especially EAAT2) in glioblastoma (GBM) impairs glutamate clearance, enhancing accumulation [457, 459, 460]. This evidence concerns the gene SLC1A3 and glioblastoma.